Validation of Oxygen Nanosensor in Mitochondrial Myopathy

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 17, 2023

Primary Completion Date

August 1, 2027

Study Completion Date

August 1, 2027

Conditions
Mitochondrial MyopathiesMitochondrial Diseases
Interventions
DEVICE

Nanosensor

"The purpose of the study is to test a device called a nanosensor, which measures oxygen levels (a proxy of mitochondrial function) in muscle. The nanosensor has not been tested in humans nor has it been approved by the FDA.~The study nanosensor measures 1.8 mm width x 6 mm length x 0.3 mm depth. Placement of the sterilized nanosensor involves a small incision for manual placement of the nanosensor in muscle forearm tissue."

Trial Locations (1)

19104

RECRUITING

The Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Children's Hospital of Philadelphia

OTHER